An independent pharmacy opted to settle a wrongful death lawsuit involving an opioid prescription.
In an effort to combat opioids, the FDA is pushing blister packs—something pharmacy groups have been advocating for.
Pharmacy groups are praising new Medicare Part D opioid limits.
Three medical groups have issued guidelines for the use of anticoagulants during cardiac surgery.
The DOAC edoxaban can replace dalteparin for treating cancer patients with venous thromboembolism.
Easy-to-swallow bits of information from around the world of pharmacy.
CMS is considering big changes to DIR fees and pharmacists are excited.
The agency’s ruling also added an additional Boxed Warning.
A protein called STUB1 may help prevent blood clots in patients with chronic kidney disease without causing bleeding complications.
Direct oral anticoagulants have expanded treatment options for patients with venous thromboembolisms, but they are not for everyone.